ペルフェナジン
ペルフェナジン · 2-クロロ-10-[3-[4-(2-ヒドロキシエチル)ピペラジン-1-イル]プロピル]フェノチアジン · 4-[3-(2-クロロフェノチアジン-10-イル)プロピル]-1-ピペラジンエタノール · ペルフェナジン (JP17) · デセンタン · 2-クロロ-10-[3-[4-(2-ヒドロキシエチル)ピペラジン-1-イル]プロピル]-10H-フェノチアジン · クロルピプラジン · トリラホン

識別子と物理属性
| CAS No. | 58-39-9 |
|---|---|
| 分子式 | C21H26ClN3OS |
| 平均分子量 | 404 g/mol |
| 単同位体質量 | 403.14851113 g/mol |
| SMILES | OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 |
| InChIKey | RGCVKNLCSQQDEP-UHFFFAOYSA-N |
| PubChem CID | 4748 |
| ChEMBL | CHEMBL567 |
| ChEBI | CHEBI:8028 |
| EC No. | 200-381-5 |
| DTXSID | DTXSID1023441 |
| 現地名 | ペルフェナジン |
化学・物理的性質
| XLogP | 4.2 |
|---|---|
| 極性表面積 | 55.3 |
| 水素結合供与体数 | 1 |
| 水素結合受容体数 | 5 |
| 回転可能結合数 | 6 |
| 重原子数 | 27 |
| 形式電荷 | 0 |
| 複雑度 | 463 |
| 医薬品 | DEA NFLIS-Drug Category -> Depressants and TranquilizersPharmaceuticals -> Listed in ZINC15 |
| pH | pH = 4.2 - 5.6 |
| LogP(分配係数) | log Kow = 4.203.94.25 |
| 臭い | Almost odorless |
| 味 | Bitter taste |
| Color/Form | CrystalsWhite to creamy-white powder |
| 溶解度 | Solubility (mg/mL): ethanol 153acetone 82practically insoluble in sesame oilIn water, 2.83X10-2 g/L (28.3 mg/L) at 24 °C2.37e-02 g/L水にほとんど溶けず、ジクロロメタンに易溶、エタノールに可溶(96%)。希塩酸溶液に可溶。28.28mg/L(24℃) |
| Human Drugs | Breast FeedingLactationMilk, HumanAntipsychotic AgentsPhenothiazinesFDA approved drugs -> Active ingredientPharmaceuticals |
| 沸点 | 278-281 °C at 1.00E+00 mm HgBP: 214-218 °C at 0.15 mm Hg278-281 at 1 mm Hgbp0.15 214-218°bp1 278-281° |
| Decomposition | When heated to decomposition it emits very toxic fumes of /sulfur and nitrogen oxides/ and /hydrogen chloride/. |
| 融点 | 97 °CCrystals from alcohol, MP: 225-226 °C /Dihydrochloride/95-98C |
| Physical Description | Solid |
| 密度 | 1.253 |
| 屈折率 | 1.6100 (estimate) |
| 貯蔵条件 | 2-8°C |
| pKa(酸解離定数) | pKa 7.8(H2O,t =24±1) (Uncertain) |
| 外観・状態 | Solid |
| 色 | 白い |
| Merck | 14,7183 |
| 安定性 | DMSO溶液またはエタノール溶液で-20°Cで最大3か月保存できます。 |
| 主な用途 | 臨床検査 |
| InChI | InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2 |
| InChIKey | RGCVKNLCSQQDEP-UHFFFAOYSA-N |
| SMILES | N1(CCO)CCN(CCCN2C3=CC(Cl)=CC=C3SC3=C2C=CC=C3)CC1 |
| CAS データベース | 58-39-9(CAS DataBase Reference) |
化学的特性
Off-White to Pale Yellow Solid
安全性と法規制
| GHS 分類 | DangerH302 (96.3%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P305+P354+P338, P316, P317, P318, P320, P321, P330, P333+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 54 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| その他の安全情報 | IMAP assessments - 1-Piperazineethanol, 4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-: Environment tier I assessment |
| FDA 要件 | The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, including perfenazine, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. |
| Hazard Classes and Categories | Acute Tox. 4 (96.3%) |
| Skin, Eye, and Respiratory Irritations | May cause irritation /to the eyes, skin, and mucous membranes/. Avoid inhalation. Remove to fresh air. Avoid contact. Flush /eyes/ with copious quantities of tepid water. Avoid /skin/ contact. Flush with copious quantities of soap and water. |
| Hazardous Reactivities and Incompatibilities | Perphenazine should not be mixed with tea as precipatation of insoluble tannates may occur. |
| 消火手順 | Water spray, dry chemical, carbon dioxide or foam as appropriate for surrounding fire and materials.As with all fires, evacuate personnel to a safe area. Firefighters should use self-contained breathing equipment and protective clothing. |
| 保管条件 | Store in tight, light-resistant container as defined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity.Commercially available preparations of perphenazine should be stored in tight, light-resistant containers. Perphenazine tablets and oral concentrate solution should be stored at 2-25 and 2-30 °C, respectivelyfreezing of the oral concentrate solution should be avoided. |
| 清掃方法 | Wear approved respiratory protection, chemically compatible gloves and protective clothing. Wipe up spillage or collect spillage using a high efficiency vacuum cleaner. Avoid breathing dust. Place spillage in appropriately labeled container for disposal. Wash spill site. |
用途
解説
ペルフェナジンは,フェノチアジン系の向精神薬。静穏作用が強く,鎮静,強化麻酔,制吐作用なども示す。同系のクロルプロマジンに比して,傾眠状態を起こすことが少なく,鎮静作用も比較的弱いが,制吐作用は非常に強い。精神病治療にも有効で,陳旧な統合失調症患者に対して,疎通性,接触性の回復および,意欲,自発性の促進作用を強く現す。副作用は嗜眠,軽度の血圧下降,パーキンソン様症状などがあるが,クロルプロマジンに比して弱い。ブリタニカ国際大百科事典 小項目事典 ブリタニカ
使用
D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. Antipsychotic.
一般的な説明
Perphenazine, 4-[3-(2-chlorophenothiazine-10-yl)propyl]piperazineethanol; 2-chloro-10-[3-[4-(2-hydroxyethyl)piperazinyl]propyl]phenothiazine(Trilafon), is an effective antipsychotic and antiemetic.